Moderna (MRNA) Net Margin Growth (1y) (2018 - 2026)

Moderna (MRNA) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Moderna 22.52 Bn 17.32 Bn -566.00 Mn 55,383.00

Historic Data

Download Data
DateValue
Mar 31, 2026 55,383.00
Dec 31, 2025 -589.00
Sep 30, 2025 -2,038.00
Jun 30, 2025 -5,028.00
Mar 31, 2025 -19,548.00
Dec 31, 2024 -12,366.00
Sep 30, 2024 19,895.00
Jun 30, 2024 -12,954.00
Mar 31, 2024 -70,784.00
Dec 31, 2023 -2,110.00
Sep 30, 2023 -22,926.00
Jun 30, 2023 -44,743.00
Mar 31, 2023 -5,604.00
Dec 31, 2022 -3,869.00
Sep 30, 2022 -3,607.00
Jun 30, 2022 -1,759.00
Mar 31, 2022 -275.00
Dec 31, 2021 11,532.00
Sep 30, 2021 21,548.00
Jun 30, 2021 23,848.00